Yahoo Web Search

    • DermTech Reports First Quarter 2021 Financial Results

      StreetInsider· 5 days ago

      LA JOLLA, Calif.--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported financial results for the quarter ended...

    • Variantyx Expands Into Prenatal, Cancer Testing

      GenomeWeb News· 7 days ago

      Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to include prenatal and pan-cancer testing in the US. The test analyzes amniotic ...